...
首页> 外文期刊>Molecular human reproduction. >Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis.
【24h】

Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis.

机译:子宫内膜异位症患者子宫内膜异位组织和细胞培养物中芳香化酶的表达。

获取原文
获取原文并翻译 | 示例

摘要

Cytochrome P-450 aromatase is responsible for catalysing the conversion of androstendione into estrone, so its expression in endometriotic tissue could contribute to the development of endometriosis. The aims of this study were, on the one hand, to determine the presence of aromatase in eutopic and ectopic endometrium, healthy peritoneum, myometrium and leiomyomas from patients with (n 61) and without endometriosis (n effect of peritoneal fluid (PF), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNFalpha) on aromatase activity from endometriotic stromal cells and subcutaneous adipocytes. After immunohistochemical analysis, aromatase expression was detected in the endometriotic tissue of 61% of patients, whereas the rest of the tissues, as well as those from disease-free women, were negative. Cell cultures were made to determine aromatase activity in endometriotic stromal cells and adipocytes. The addition of PF, TNFalpha and especially IL-6 (P < 0.05) stimulated the basal enzymatic activity observed in both cell types. Our findings confirm the presence of aromatase in endometriosis and probably the existence of a local estrogen production that may be stimulated by some factors such as cytokines present in the PF of these patients. Therefore, the use of aromatase inhibitors combined with immunomodulator agents could be a novel approach to be investigated in future clinical trials.
机译:细胞色素P-450芳香化酶负责催化雄烯二酮向雌酮的转化,因此其在子宫内膜异位组织中的表达可能有助于子宫内膜异位症的发展。这项研究的目的是,一方面确定来自(n = 61)无子宫内膜异位症(n腹膜液(PF),白细胞介素6(IL-6)和肿瘤坏死因子-α(TNFalpha)对子宫内膜异位基质细胞和皮下脂肪细胞芳香化酶活性的影响。免疫组织化学分析,61%的患者子宫内膜异位组织中检测到芳香化酶表达组织和无病妇女的组织均为阴性,进行细胞培养以确定子宫内膜异位基质细胞和脂肪细胞中的芳香化酶活性,添加PF,TNFα,尤其是IL-6(P <0.05)我们的发现证实了子宫内膜异位症中存在芳香化酶,并且可能存在某些雌激素可能刺激了局部雌激素的产生。这些患者的PF中存在诸如细胞因子之类的激素。因此,结合使用芳香化酶抑制剂和免疫调节剂可能是在未来的临床试验中研究的一种新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号